Skip to main content
. 2021 May 19;10(10):2191. doi: 10.3390/jcm10102191

Figure 3.

Figure 3

Relationship of immune modulators in combination with CD274 (PD-L1) and survival in CCA patients. The Kaplan–Meier survival curves in SurvExpress CCA patients for the gene expression of (A) CD274/IDO1, (B) CD274/NT5E, (C) CD274/CD80, (D) CD274/FASLG, (E) CD274/HAVCR2, (F) CD274/LGALS9, (G) CD274/TNFRSF14 and (H) CD274/VTCN1. Low-risk groups are indicated in green and high-risk groups are indicated in red. The x-axis presents the study time in months. HR, CI and p-values are shown in the insert.